Jin H. Zhou

155 North Nanjing Street
Shenyang, 110001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

L1CAM enhances autophagy via inhibition of p38 phosphorylation in colorectal cancer development and progression.

L1CAM enhances autophagy via inhibition of p38 phosphorylation in colorectal cancer development and progression.

Journal: Genes & genomics

Published: July 27, 2025

Cell-free extracts from human fat tissue attenuate ischemic injury in cardiomyocytes in a murine model.

Cell-free extracts from human fat tissue attenuate ischemic injury in cardiomyocytes in a murine model.

Journal: World journal of stem cells

Published: January 21, 2025

Ghrelin ameliorates sepsis-induced acute skeletal muscle wasting via hypothalamic JAK2/STAT3-AgRP pathway.

Ghrelin ameliorates sepsis-induced acute skeletal muscle wasting via hypothalamic JAK2/STAT3-AgRP pathway.

Journal: International journal of surgery (London, England)

Published: January 08, 2025

Enhanced design of pCMViR-TSC plasmid vector for sustainably high cargo gene expression in mammalian cells.

Enhanced design of pCMViR-TSC plasmid vector for sustainably high cargo gene expression in mammalian cells.

Journal: In vitro cellular & developmental biology. Animal

Published: October 06, 2024

Correction: S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway.

Correction: S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway.

Journal: In vitro cellular & developmental biology. Animal

Published: June 27, 2024

S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway.

S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway.

Journal: In vitro cellular & developmental biology. Animal

Published: March 06, 2024

Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axis.

Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axis.

Journal: Frontiers in oncology

Published: February 07, 2024

Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface.

Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface.

Journal: Frontiers in oncology

Published: January 16, 2024

Hearing intervention for decreasing risk of developing dementia in elders with mild cognitive impairment: study protocol of a multicenter randomized controlled trial for Chinese Hearing Solution for Improvement of Cognition in Elders (CHOICE).

Hearing intervention for decreasing risk of developing dementia in elders with mild cognitive impairment: study protocol of a multicenter randomized controlled trial for Chinese Hearing Solution for Improvement of Cognition in Elders (CHOICE).

Journal: Trials

Published: August 20, 2023

LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells.

LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells.

Journal: Frontiers in oncology

Published: January 12, 2023

Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2.

Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2.

Journal: Frontiers in oncology

Published: January 12, 2023

Biallelic p.V37I variant in GJB2 is associated with increasing incidence of hearing loss with age.

Biallelic p.V37I variant in GJB2 is associated with increasing incidence of hearing loss with age.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 11, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026